Skip to main content

Medical Tourism Market Is Expected To Grow with a Healthy CAGR During 2020-2027

  Traveling to overseas for affordable and state-of-the-art medical care and treatment is basically termed as medical tourism. Years back, people from developing countries used to travel to highly developed countries seeking advanced and safer treatment, which was barely available in their own countries. Today, people from developed countries travel to developing countries for cost-effective medical treatments, which has slightly changed the traditional concept of medical tourism.

The medical tourism market share is predicted to rise at a CAGR of 12.4% and is expected to reach $149.34 Million till 2026. Earlier, in 2018, market was valued $58.62 Billion.

Medical tourism means when a person travels to the other country to undergo a treatment. This is usually done by the patient when the medication is more expensive in their respective country or due to the unavailability of advanced medication and machinery in their home country. Basically, medical tourism is the combination of medical treatment and travel at the same time. It means that one travels to another country for medical purposes spending a few days abroad and combines a vacation with the medical procedure.

For More Detail Insights, Download FREE Sample Copy of the Report at: https://www.researchdive.com/download-sample/75

The high cost of treatment in the home country and the availability of advanced medical facilities in the developing countries is predicted to drive the medical tourism market. Affordability and convenience of the good medical facilities with the guidance from the tourism department is expected to drive the medical tourism industry. For instance, in the U.S the cost spend for heart surgery will be almost 80% more than the total cost spends in Asian countries. So, due to these factors, many developed countries patients are preferring to get treated in the developing nation or the nation with high medical facilities with lesser cost for the treatment; these factors are predicted to boost the global medical tourism industry.

Private healthcare is expensive and many insurance companies don’t cover the insurance. There are many circumstances the patient has to face with regards to their insurance policy and regulation. For instance, insurance may not be covered by the company if the treatments are carried out overseas; if the insurance is covered then the insurance companies don’t pay the airfare and extra expenditures. Due to reimbursement policies, patients are forced to stay at their home country and get treated which is consider to be the major restraint for the medical tourism market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/75

On the basis of the service type, medical tourism market size for Cosmetic segment is projected to generate a revenue of $31,063.9 million by 2026 with a CAGR of 11.9% in the forecast period. The curiosity of people to look different and change their appearance to keep themselves confident is predicted to boost the cosmetic treatment segment in the forecast period. Cancer treatment is projected to have the highest growth rate in the estimated period. The Medical tourism market share for cancer treatment is estimated to rise at a CAGR of 14.2% by generating a revenue of $7,616.6 million by 2026. The rise in occurrences of cancer worldwide is estimated to boost the cancer treatment segment. The treatment of cancer takes a lot of time, and patients prefer going outside their home country for their treatment due to better medical amenities with lesser cost. Medical tourism market forecast that cancer treatment segment in medical tourism market is going to experience a boost the in the forecasted period.

Based on the region segmentation Asia-Pacific has the highest growth rate. Asia-Pacific region is estimated to rise with a CAGR of 12.2% by generating a revenue of $54,452.9 million by 2026. The Asia-Pacific region provides all the medical amenities at a reasonable price so that the patient can afford it and can be cured. Due to the tourism friendliness and government policies with regards to tourism not being that strict, patients prefer the Asia-Pacific region to get them treated. These factors will boost the medical tourism market in this region.

The major key companies in the market are Prince Court Medical Centre, Aditya Birla Memorial hospital, KPJ Healthcare Berhad, UZ Leuven, Apollo Hospitals Enterprise Ltd, Fortis Healthcare, NTT Medical Centre, Asklepios Kliniken GmbH, Bumrungrad International Hospital, KPJ Healthcare Berhad and Asian Heart Institute among others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Popular posts from this blog

COVID-19 Impact: What Challenges Critical Care Devices Market May See In Next 5 Years?

   The coronavirus outbreak has influenced the critical care devices industry fairly and positively. Expanded usage of critical care devices is expected to fuel the demand for COVID-19 care during the forecast era. Markets are projected to provide investors with more growth prospects over time. Leading players of the market are predicted to unlock vibrant opportunities for the growth of the market in the forthcoming years by taking various initiatives. The latest research report on the global critical care devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe. For More Detail Insights, Download FREE Sample at:   https://www.researchdive.co...

GLOBAL FLUOROETHYLENE CARBONATE(FEC) INDUSTRY: HUGE GROWTH OPPORTUNITIES, FORECAST TO 2025

The evaluation of the various elements of the global Fluoroethylene Carbonate(FEC) Industry dynamics is highly sought after by stakeholders of all types and entrepreneurs planning to make a foray into the market. The study on the global Fluoroethylene Carbonate(FEC) Industry is prepared with the help of several rounds of primary research and a vast spectrum of secondary research . The application of industry-wide statistical methods to the large amount of data generated further ads credibility to the analyses. The study on the global and regional Fluoroethylene Carbonate(FEC) Industry dynamics is a crucial guide to all those stakeholders, especially regulatory agencies and policy makers . Summary of Market: The global Fluoroethylene Carbonate(FEC) Industry is valued at xx million US$ in 2019 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025 . This report focuses on Fluoroethylene Carbonate(FEC) Industry volume and value at global ...

What are the Left Atrial Appendage Closure Devices Market Key Insights and COVID-19 Business Impact?

   Download FREE Sample Connect with Analyst The COVID-19 outbreak has significantly affected the global left atrial appendage closure devices market. As per American Heart Association, people having high blood pressure, heart valve disease and congenital heart diseases are expected to develop severe coronavirus symptoms. Also, this virus can generate heart strokes through weakening of muscles of the heart. These fators will boost the demand for left atrial appendage closure divices and surge the market growth during the pandemic. Furthermore, the leading manufactures in the global market are adopting various strategies such as product innovations and partnerships to increase their market share in the overall industry. For example, in July 2020, Boston Scientific Corporation announced that the “Watchman FLX left atrial appendage closure device” has been approved by U.S. Food and Drug Administration, which is used to minimize the threat of heart stroke in patients. The stroke r...